Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
With
Novartis
There is a need for effective therapy for dry eye that treats the underlying cause of the syndrome. The goal of this study is to assess the impact of rebamipide on dry eye symptoms.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
must have symptoms of dry eye for a minimum of 6 months
must be able to sign and date an informed consent
You may not be if
presence of anterior segment disease
glaucoma or ocular hypertension
using Restasis
use of topically instilled ocular medications during study
use of contact lenses
history of ocular surgery within 12 months
females who are pregnant, breast feeding, or child-bearing potential and not willing to remain abstinent or use contraception
presence of Stevens-Johnson syndrome
any anticipated change in medication through-out study
concurrent involvement in another study or previous receipt of this drug
cannot be safely be weaned off of ocular medications
Clareo Health | Study of Rebamipide Eye Drops to Treat Dry Eye
